New pump may bring comfort to Parkinson's patients in final days

NCT ID NCT07257861

Recruiting now Symptom relief Sponsor: Centre Hospitalier Régional d'Orléans Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a continuous apomorphine pump can reduce stiffness and improve comfort in Parkinson's patients who are near the end of life and can no longer take oral medications. Researchers will follow 80 patients receiving home hospital care, measuring symptoms like rigidity, pain, and agitation over 45 days. The goal is to see if this approach can ease suffering for patients and their caregivers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: apomorphine
What this could lead to: If it works, this could offer a way to reduce suffering and improve comfort for Parkinson's patients in their final days.
What could go wrong: This is a small, early-stage study with only 80 participants, and results may not apply to all patients. The pump may cause side effects like skin reactions or nausea.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Death Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON DISEASE

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Had Crest
RECRUITING

Crest, France

Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.